The Bank of New York Mellon Appointed Depositary Bank by Biovitrum AB

PRNewswire
NEW YORK
(NYSE:BK)
Jul 7, 2009

NEW YORK, July 7, 2009 — The Bank of New York Mellon (NYSE: BK), the global leader in asset management and securities servicing, has been selected by Biovitrum AB as the depositary bank for its American depositary receipt (ADR) program. Each Biovitrum ADR represents one ordinary share. The ADRs trade on the over-the-counter (OTC) market. Biovitrum's ordinary shares trade on the Stockholm OMX Nordic Exchange under the symbol "BVT."

Biovitrum is an international pharmaceutical company that markets specialist pharmaceuticals in several regions globally. Using its expertise and experience, Biovitrum helps bring scientific innovation to patients with significant unmet medical need. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care, and malabsorption. At year end 2008 the company had revenues of approximately SEK 1.2 billion ($153MM) and has around 400 employees.

"We are pleased with this agreement with The Bank of New York Mellon as it has a strong and proven track record," said Martin Nicklasson, chief executive officer of Biovitrum. "We wish to optimize U.S. investor access to our company, and we believe The Bank of New York Mellon has the resources and expertise necessary to help us achieve that goal."

"We look forward to helping Biovitrum unlock the potential of the U.S. capital markets," said Michael Cole-Fontayn, chief executive officer of The Bank of New York Mellon's Depositary Receipt Division. "As the world's leading depositary, The Bank of New York Mellon will utilize its resources to develop a long and mutually beneficial partnership with Biovitrum and its investors."

The Bank of New York Mellon acts as depositary for more than 2,100 American and global depositary receipt programs, acting in partnership with leading companies from 67 countries. With an unrivalled commitment to helping securities issuers succeed in the world's rapidly evolving financial markets, the Company delivers the industry's most comprehensive suite of integrated depositary receipt, corporate trust and stock transfer services. Additional information is available at www.bnymellon.com/dr.

The Bank of New York Mellon Corporation is a global financial services company focused on helping clients manage and service their financial assets, operating in 34 countries and serving more than 100 markets. The company is a leading provider of financial services for institutions, corporations and high-net-worth individuals, providing superior asset management and wealth management, asset servicing, issuer services, clearing services and treasury services through a worldwide client-focused team. It has $19.5 trillion in assets under custody and administration, $881 billion in assets under management, services more than $11 trillion in outstanding debt, and processes global payments averaging $1.8 trillion per day. Additional information is available at www.bnymellon.com.

This release is for informational purposes only. The Bank of New York Mellon provides no advice nor recommendation or endorsement with respect to any company or securities. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities. Depositary Receipts: Not FDIC, State or Federal Agency Insured; May Lose Value; No Bank, State or Federal Agency Guarantee.